Fosun Pharma to buy France’s Tridem for $73 million

Industry:    2017-10-30

Shanghai Fosun Pharmaceutical (Group) Co. Ltd said it would buy French drug distributor Tridem Pharma S.A.S. for €63 million ($73 million), in a move to expand its market share in Europe and Africa.

The Chinese drug maker said in a statement that it will buy shares in Tridem from major shareholders including Financière des Lices, Multicroissance, and a French fund FCPR PMC II.

Tridem has a sales network covering 21 French-speaking African countries and regions.

This month, Fosun Pharma bought 74% of India’s Gland Pharma for around $1.1 billion. Reuters

print
Source: